EMCDDA news

By Gregor Burkhart, Principal scientific analyst — prevention, EMCDDA 30.10.2020 

Save the date — 12 November: Latest ESPAD report 23.10.2020  The latest European data and analysis on substance use and risk behaviours among 15–16-year-old school students will be released in a new report on 12 November. The findings are based on a 2019 survey in 35 European countries conducted by the European School Survey Project on Alcohol and Other Drugs (ESPAD). A total of 99 647 students participated in the latest survey round. The ESPAD Report 2019 is published in collaboration with the EU drugs agency (EMCDDA).

Substitution treatment for stimulants users? Finding a pharmacological treatment for stimulant users has been a research priority for the last decade. Many classes of drugs have been tested: antidepressants, dopamine agonists, antipsychotics, anticonvulsants, disulfiram, opioid agonists, N-Acetylcysteine; without conclusive results. 20.10.2020 

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS) (1)(2). 19.10.2020 

This content was published in the EU4MD update released on 01.10.2020. This update also presents a section on studies, upcoming events, and a research corner. 01.10.2020